AI assistant
Twist Bioscience Corp — Director's Dealing 2018
Oct 30, 2018
31873_dirs_2018-10-30_596ebf73-f10c-4856-95fc-d739884e0951.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2018-10-30
Reporting Person: CRAVES FRED B (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 0 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series B Preferred Stock | $ | Common Stock (51010) | Indirect | ||
| Series C Preferred Stock | $ | Common Stock (7158) | Indirect | ||
| Series D Preferred Stock | $ | Common Stock (8603) | Indirect |
Footnotes
F1: The Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock have no expiration date and automatically convert into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering.
F2: The Reporting Person is a trustee of The Craves Family Foundation. The Reporting Person may be deemed to have voting and dispositive power over the shares held of record by The Craves Family Foundation. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.